499 related articles for article (PubMed ID: 25992776)
1. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
Denk J; Boelmans K; Siegismund C; Lassner D; Arlt S; Jahn H
PLoS One; 2015; 10(5):e0126423. PubMed ID: 25992776
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
3. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
Wang WX; Rajeev BW; Stromberg AJ; Ren N; Tang G; Huang Q; Rigoutsos I; Nelson PT
J Neurosci; 2008 Jan; 28(5):1213-23. PubMed ID: 18234899
[TBL] [Abstract][Full Text] [Related]
4. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R
J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582
[TBL] [Abstract][Full Text] [Related]
5. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
Paltsev MA; Zuev VA; Kozhevnikova EO; Linkova NS; Kvetnaia TV; Polyakova VO; Kvetnoy IM
Adv Gerontol; 2017; 30(6):809-817. PubMed ID: 29608821
[TBL] [Abstract][Full Text] [Related]
6. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
[TBL] [Abstract][Full Text] [Related]
8. Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults.
Sadlon A; Takousis P; Evangelou E; Prokopenko I; Alexopoulos P; Udeh-Momoh CM; Price G; Middleton L; Perneczky R
J Prev Alzheimers Dis; 2024; 11(1):230-240. PubMed ID: 38230736
[TBL] [Abstract][Full Text] [Related]
9. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
Kiko T; Nakagawa K; Tsuduki T; Furukawa K; Arai H; Miyazawa T
J Alzheimers Dis; 2014; 39(2):253-9. PubMed ID: 24157723
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
14. BACE1 levels correlate with phospho-tau levels in human cerebrospinal fluid.
Barao S; Zhou L; Adamczuk K; Vanhoutvin T; van Leuven F; Demedts D; Vijverman AC; Bossuyt X; Vandenberghe R; De Strooper B
Curr Alzheimer Res; 2013 Sep; 10(7):671-8. PubMed ID: 23566348
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
[TBL] [Abstract][Full Text] [Related]
16. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
17. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
18. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
19. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]